scholarly article | Q13442814 |
P356 | DOI | 10.1006/GENO.1996.0158 |
P698 | PubMed publication ID | 8617509 |
P50 | author | Lindsay A. Farrer | Q37380266 |
John Growdon | Q67217951 | ||
Jonathan L Haines | Q73570557 | ||
James F. Gusella | Q1602688 | ||
P2093 | author name string | M A Pericak-Vance | |
A D Roses | |||
G W Small | |||
P M Conneally | |||
P C Gaskell | |||
S A Auerbach | |||
A M Saunders | |||
J M Schildkraut | |||
P A Locke | |||
B L Rosi | |||
L Yamaoka | |||
M L Pritchard | |||
P433 | issue | 1 | |
P304 | page(s) | 53-56 | |
P577 | publication date | 1996-04-01 | |
P1433 | published in | Genomics | Q5533503 |
P1476 | title | No genetic effect of alpha1-antichymotrypsin in Alzheimer disease. | |
P478 | volume | 33 |
Q53216211 | Absence of the A1252G mutation in alpha 1-antichymotrypsin in a North American population suffering from dementia. |
Q35091381 | Alpha-1-antichymotrypsin (ACT or SERPINA3) polymorphism may affect age-at-onset and disease duration of Alzheimer's disease |
Q53328886 | Alpha-antichymotrypsin gene polymorphism and risk for Alzheimer's disease in the Spanish population. |
Q53220741 | Alpha1-antichymotrypsin polymorphism in Japanese cases of Alzheimer's disease. |
Q34208401 | Amyloid precursor protein (APP) and the biology of proteolytic processing: relevance to Alzheimer's disease |
Q53230050 | Apolipoprotein E and alpha-1-antichymotrypsin allele polymorphism in sporadic and familial Alzheimer's disease. |
Q53247598 | Apolipoprotein E and alpha-1-antichymotrypsin genotypes do not predict time to psychosis in Alzheimer's disease. |
Q53095034 | Association between α1-antichymotrypsin signal peptide -15A/T polymorphism and the risk of Alzheimer's disease: a meta-analysis. |
Q73540046 | Association of serum AACT levels and AACT signal polymorphism with late-onset Alzheimer's disease in Northern Ireland |
Q33714955 | Clinical rationale of genetic testing in dementia |
Q28578893 | Effect of cytokines, dexamethasone and the A/T-signal peptide polymorphism on the expression of alpha(1)-antichymotrypsin in astrocytes: significance for Alzheimer's disease |
Q35882298 | Evidence for major gene inheritance of Alzheimer disease in families of patients with and without apolipoprotein E epsilon 4 |
Q53329766 | Genetic association studies between Alzheimer's disease and two polymorphisms in the low density lipoprotein receptor-related protein gene. |
Q33588353 | Genetic risk factors in Alzheimer's disease |
Q53222439 | Genetic risk factors in Japanese Alzheimer's disease patients: alpha1-ACT, VLDLR, and ApoE. |
Q37610265 | Genomics of immune molecules: early detection of cognitive decline and new therapeutic interventions |
Q36607337 | Impaired regulation of immune responses in cognitive decline and Alzheimer's disease: lessons from genetic association studies |
Q58451980 | Implication of α1-antichymotrypsin polymorphism in familial Alzheimer's disease |
Q41712475 | Interaction of apolipoprotein E epsilon 4 with other genetic and non-genetic risk factors in late onset Alzheimer disease: problems facing the investigator |
Q73327181 | Lack of association between alpha1-antichymotrypsin polymorphism and late-onset depressive disorder |
Q33842568 | Molecular genetics of Alzheimer's disease. |
Q35821959 | Molecular genetics of late-onset Alzheimer's disease. |
Q35009772 | Neuroinflammation and anti-inflammatory therapy for Alzheimer's disease |
Q53215696 | No association between alpha 1-antichymotrypsin and familial Alzheimer's disease. |
Q73655866 | No association between alpha1-antichymotrypsin polymorphism, apolipoprotein E and patients with late-onset Alzheimer's disease |
Q47712672 | No association of alpha1-antichymotrypsin flanking region polymorphism and Alzheimer disease risk in early- and late-onset Alzheimer disease patients |
Q33760959 | Progress toward valid transgenic mouse models for Alzheimer's disease |
Q34108351 | The genetics of Alzheimer's disease |
Q73745521 | The genetics of Alzheimer's disease |
Search more.